Stroke Recovery Animal Models & CRO Services

Stroke Recovery Animal Models & CRO Services - Preclinical Research - Animal models of stroke recovery. Stroke affects people of all ages. There are approximately 7 million stroke survivors in the U.S. Stroke commonly results in substantial and multi-dimensional disability in patients, including disturbances in walking, speech, arm function, balance, memory, vision, swallowing, etc.

Some degree of recovery is common after stroke. However, other than physical, occupational, and speech therapies, there are no drugs, devices, or cell therapies currently on the market that accelerate or enhance recovery after stroke.

Biotrofix investigators were among the pioneers in the development of animal models of stroke recovery. These include rat models of focal stroke, compatible with long survival of animals, suitable for investigation of recovery-promoting treatments. Such treatments are typically administered days after stroke onset. Endpoints for these studies include serial behavioral evaluation of animals and histology.

Download STROKE RECOVERY MODEL (.pdf)

Home The Company Preclinical Research Services The Team News Publications Contact Us Site Map

Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development.